Articles for Vectura Group (LSE: VEC)

Warning! I reckon this FTSE 100 stock could fall off a cliff in 2019

Rupert Hargreaves thinks it's only a matter of time before this high-flying FTSE 100 (INDEXFTSE: UKX) growth stock falls back to earth. More »

Why I’d buy this flying FTSE 100 stock today and hold it for decades

This FTSE 100 (INDEXFTSE:UKX) business has outstanding credentials for buy-and-hold investors, says G A Chester. More »

Could these 2 pharma growth stocks help you retire early?

Harvey Jones sees plenty to like in these two pharmaceutical stocks, but plenty of uncertainties too. More »

One FTSE 100 income champion and one growth star that could help you retire early

The combination of income and growth from this FTSE 100 (INDEXFTSE: UKX) market leader and its peer could help you retire early. More »

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright. More »

Should I swap GlaxoSmithKline plc for this turnaround stock?

Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)? More »

Top stocks for December

We asked our analysts to share their top stock picks for the month. More »

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). More »

These growth stocks are trading at major discounts

Are these two companies cheap enough to merit purchase right now? More »

Top stocks for June

We asked our analysts to share their top stock picks for the coming month. More »

Are these bombed-out pharma stocks worth buying?

Should you catch these falling knives? More »

2 FTSE 250 bargains I’d buy before it’s too late

These FTSE 250 (INDEXFTSE:MCX) stocks look set for strong growth. More »

Forget short-term pain: 2 growth stocks for long-term gain!

Royston Wild discusses two growth lovelies for long-term investors. More »

Why this growth stock could double by 2019

Bilaal Mohamed reckons this pharmaceutical stock could double within the next couple of years. More »

2 shares with explosive long-term growth potential

These stocks have the potential to produce growth for years to come. More »

3 growth stocks I’d buy right now

The next few years could see rich pickings among growth shares. More »

Top stocks for February

We asked our analysts to share their top stock picks for the coming month. More »

One growth stock I’d buy and one I’d sell in February

G A Chester reveals one mid-cap he'd buy and one he'd sell. More »

Why I see 50% upside in this pharmaceutical firm in 2017

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year. More »

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)? More »